XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 67 filers reported holding XENON PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9 | -10.0% | 252 | 0.0% | 0.00% | – |
| Q2 2023 | $10 | +11.1% | 252 | 0.0% | 0.00% | – |
| Q1 2023 | $9 | -10.0% | 252 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 252 | +27.3% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 198 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 198 | +40.4% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 141 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 141 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 141 | +113.6% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 66 | -60.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 165 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |